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Abstract
Purpose of Review Microfluidic platforms have become valuable tools in a wide variety of research environments. With the
ability to allow detailed examination of an array of cell biological processes, their use in the field of virology is becoming
progressively more common. This review will discuss the potential applications of microfluidics in viral cell biology and explore
the potential of these techniques to alter the way in which we study the biology of infection.
Recent Findings In recent years, scientists have utilised microfluidic platforms for detailed study of the viral life cycle.
Microfluidic technologies have allowed investigation of viral infectivity, measurement of fusion kinetics, and monitoring of
viral responses to neutralising compounds. In addition, microfluidic platforms represent promising new clinical tools with
applications in diagnostics and drug screening.
Summary Although the potential of microfluidics in virology is beginning to be realised, it has certainly not been fully explored.
While not a replacement for macroscale investigative techniques, microfluidic platforms have the potential to be utilised along-
side systems biology to provide novel methods of detailed virus study, with unique advantages.
Keywords Virus microfluidics . Virus entry . Viral cell biology . Fluorescence imaging . Single particle . Single-cell analysis
Introduction
Microfluidics can be thought of as both a science and a tech-
nology. The term specifically describes a range of techniques
concerned with the precise control and manipulation of fluids,
within microscopic channels [1]. This relatively straightfor-
ward concept underpins an array of biological research tech-
niques, from flow cytometric and DNA analyses to enzyme
and immunoassays [2, 3]. With the potential to expand exper-
imental approaches in a wide variety of scientific fields,
microfluidics could represent a novel set of explorative tech-
niques in the fields of cell and infection biology.
In order to fully appreciate the potential of microfluidic
platforms in scientific research, it is first necessary to under-
stand the basic principles and components of a typical
microfluidic device. Microfluidic technologies are primarily
based upon the theories of fluid mechanics: While fluid flow
on a macroscale is likely to be turbulent and unpredictable,
fluids on a microscale move consistently in laminar flow [3].
Solutions in laminar flow make attractive entities for experi-
mentation since they are highly predictable and therefore offer
researchers the opportunity to precisely manipulate experi-
mental environments (Fig. 1(A)).
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Microfluidic devices typically consist of mechanical
pumps that facilitate fluid motion and a network of
microchannels, within which target fluids are transported
and experimental interfaces are present [4] (Fig. 1(E, F)).
Most systems also contain devices that regulate physical con-
ditions within the platform such as temperature and pH level.
Fluids within a device typically move either in continuous,
laminar flow, or as finite volumes suspended in sheath fluid,
which is known as droplet-based or digital microfluidics.
Droplet-based microfluidics, a specialised platform often
utilised for single-cell analysis, has become a key research
technique in cell biology (Fig. 1(E, F)). These platforms create
homogeneous, microscopic droplets within an immiscible
sheath fluid, which serve as specialised microenvironments
for experimentation. Reprogrammable and reusable static
droplet array (SDA) microfluidic devices have been recently
reported, with the ability to allow precise droplet formation,
transportation, fusion, and observation [5].
Polydimethylsiloxane (PDMS) is generally the material of
choice for microfluidic chip fabrication due to its compatibility
with soft lithography techniques for microstructure moulding.
PDMS is both gas permeable and transparent, making it ideal
for both cell culture and live imaging [6]. The physical char-
acteristics of PDMS, including its high elasticity, are also par-
ticularly advantageous for cell trapping and alignment within
microfluidic devices, to be used for imaging studies [7].
Microfluidic platforms can provide numerous advantages
to biomedical scientists, over traditionally used experimental
techniques (Fig. 1(A–D)), especially when sample volumes
are a limiting factor. By drastically reducing the scale on
which experiments can be performed, they decrease both sam-
ple and reagent consumption, cutting costs and allowing anal-
yses, evenwhen a limited volume of sample is available [8]. In
numerous biochemical assays, limited sample size can result
in unreliable results. Sample analysis using a microfluidic set-
up may circumvent these issues in that samples are minimally
diluted and detection thresholds are significantly lowered due
to the reduced reaction volumes involved [2]. The precise
regulation of experimental conditions provided by a
microfluidic platform also provides researchers with a higher
degree of control over the physical and chemical environment
during their investigations. In the field of viral cell biology,
where both temperature and pH level can greatly impact in-
fection dynamics, these characteristics are particularly valu-
able. In addition, as a consequence of laminar flow character-
istics, a high degree of spatial and temporal resolution can be
achieved using microfluidic technologies, via precisely regu-
lated diffusion of samples or test compounds [4] (Fig. 1(C)).
For example, precise chemical concentration gradients created
in fluid streams adjacent to those in laminar flow provide a
stable and accurate method for drug delivery within a
microfluidic chip [9, 10].
Fig. 1 (A–D) Typical features of microfluidic set-ups and their
advantages over traditionally used techniques. (A) Fluids within
microchannels move uniformly in laminar flow, creating highly
predictable experimental environments. (B) Droplet-based microfluidic
systems allow isolation of single cells and viruses within specialised
microenvironments. (C) Precise application and subsequent diffusion of
test compounds allow for the creation of precise concentration gradients.
(D) Coupling microfluidic devices to fluorescent microscopes can allow
both live imaging of dynamic infection processes and sorting of cells
based on infection status. (E) A typical droplet-based microfluidic chip
with key components labelled. (F) A fluorescence-based, microfluidic
cell sorting device with key components labelled
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Coupling microfluidic devices to live imaging platforms
has also proven to be highly useful, allowing the extraction
of both qualitative and quantitative data, during a single ex-
periment [2] (Fig. 1(D)). Microfluidic set-ups also allow sci-
entists to perform thousands of individual experiments in par-
allel within a single device, increasing the throughput of nu-
merous investigations [4]. Since microfluidic platforms allow
for the collection of complex dynamic information during
imaging experiments at high spatial and temporal resolution,
they may in some instances provide significant advantages
over macroscale experimental approaches. While collabora-
tion may be necessary to set up and establish an efficient
platform, in studies where minimal sample use and environ-
mental control are paramount, application of microfluidics
may provide a unique investigative platform with enhanced
capabilities.
With a broad range of applications from 3D cell culture and
single-cell analysis to protein crystallisation [11] and drug
screening, microfluidic technologies have an enormous range
of uses that have collectively benefitted an array of industries
in previous years. In recent times, microfluidic techniques have
been successfully implemented in the field of cell biology for
the study of the cellular transcriptome and proteome and ex-
amination of the mechanical properties of the cytoskeleton, all
at single-cell resolutions [2]. While several microfluidics-
based set-ups have become mainstays in the field of biomedi-
cal science, tailored application of microfluidic techniques to
the study of viral biology is a somewhat neglected field of
research. In recent years, several studies have implemented
microfluidic platforms for the study of viral cell biology, with
promising results. Further application of microfluidics in the
field and development of novel experimental platforms for use
alongside systems biology-based approaches has the potential
to alter the landscape of investigative techniques in the field of
infection biology research.
Microfluidics in Virological Research
Microfluidic Platforms in Viral Diagnostics
The development of point-of-care viral diagnostic devices re-
mains an active area of clinical research and represents an
essential precursor to successful treatment for a wide variety
of human pathogens. Notably, several recent reports describe
the use of CRISPR-based nucleic acid amplification methods
for rapid diagnosis of HPV, dengue, and zika viruses [12–14].
Similarly, in recent years, microfluidic technologies have been
investigated for clinical diagnostic purposes, with several plat-
forms demonstrating efficacy for the correct and swift identi-
fication of viral infections.
One recent study demonstrated that parallel detection of
multiple viral pathogens can be achieved using a microfluidic
chamber containing numerous channels within which, viral
DNA may be amplified to form hydrogels. Following hydro-
gel formation, blockages in fluid flow and subsequent viral
infection can be detected via dye injection [15]. The fact that
RNAvirus detection relies on previous reverse transcription to
produce detectable cDNAs may be a limitation of this tech-
nique. However, since DNA constructs are likely to be stable
for some time within a microfluidic chip, this system may be
compatible with point-of-care diagnoses should chips be pre-
pared and available in advance. Moreover, since the described
methodology could be applied for the detection of a wide
variety of viruses, this relatively simple set-up may hold po-
tential for viral diagnostics in regions where sophisticated ex-
perimental machinery is unavailable and/or there is a lack of
electricity. Validation of this detection method, using sera
from virus-infected patients will be the next important step
to determine its clinical relevance.
Several microfluidic set-ups utilising antibody-based viral
detection have also been recently described [16, 17•]. In one
of these studies, a microfluidic platform for the diagnosis of
dengue virus (DV) via host antibody recognition was shown
to improve detection thresholds relative to previously used
diagnostic techniques, including PCR and enzyme-coupled
immunoassays [16]. However, since adaptive antibody re-
sponses in an infected host can take several days to develop
post-pathogen exposure, host-generated antibodies may be
less reliable infection markers for patients presenting with
clinical symptoms immediately after infection. This study,
however, demonstrated an important proof of principle, in that
microfluidic technologies enabled sensitive detection of target
antibodies. In a similar experimental platform, monoclonal
antibodies directed against viral nucleoprotein (NP) were
utilised within an integrated microfluidic chip for the identifi-
cation of influenza A or B virus (IAV/IBV). Samples contain-
ing influenza viral particles were first bound to magnetic
beads and subsequently incubated with fluorescently tagged,
anti-viral antibodies. Samples could be imaged via fluores-
cence microscopy to allow swift detection of infection follow-
ing viral immunofluorescent labelling [17•]. One alternative to
antibody detection, which can also be utilised by microfluidic
platforms, involves aptamers, peptide molecules that can be
designed to target any given protein [18, 19]. A recent study
investigating the use of an integrated microfluidic system for
diagnostic purposes utilised aptamers against IAV (H1N1) for
viral detection [20•].
Collectively, these studies demonstrate that microfluidic
techniques allow for the incorporation of a variety of viral
detection methods. While the optimal microfluidic platform
for clinical diagnostic purposes remains to be ascertained,
microfluidic platforms themselves represent novel technolo-
gies with several strong selling points for clinicians.
Firstly, the pathogen detection time in numerous diagnostic
tests utilising microfluidics tends to be extremely short, with
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infections confirmed within 15–30 min [15, 16, 20•]. Since
prompt treatment following infection is often paramount for
the success of anti-viral agents, point-of-care devices which
do not require lengthy sample processing procedures may
greatly improve the success of treatment. In addition, detec-
tion thresholds in microfluidic-based systems have been dem-
onstrated to be significantly lower than those in conventional
assays for viral diagnosis such as enzyme-based immunoas-
says and PCR techniques for molecular diagnosis [15, 16,
20•]. The ability to correctly diagnose even low-level infec-
tions gives microfluidic platforms a huge potential in the field
and may significantly reduce false negative diagnostic tests.
These factors make microfluidic devices ideal candidates for
the development of novel, clinical diagnostic tools.
In addition to detection, viral concentration in clinical sam-
ples is possible using microfluidic techniques [21]. One such
system utilised microfluidic channels which contained both
fluid and gaseous compartments, separated by a hydrophobic
membrane. As sample fluid moves through the channel, evap-
oration through the pores in the membrane facilitates sample
volume reduction and pathogen concentration [21]. Since low
concentrations of pathogenic material are a common problem
in diagnostics, pre-processing with such a microfluidic device
may increase the sensitivity of pathogen detection.
Microfluidics in Anti-viral Drug Discovery and Vaccine
Development
Microfluidic technologies are a promising set of techniques
for drug discovery and have been employed in several fields
of research to test compound efficacy. Significant validation
of the usefulness of microfluidics in drug screening comes
from the field of cancer research, in which several studies have
utilised microfluidic chips for high-throughput screening
(HTS) of numerous anti-cancer agents [22, 23]. In the field
of virology, microfluidic techniques have yet to be widely
applied to screening experiments; however, the proof-of-
principle studies in cancer research indicate that these plat-
forms could be valuable research tools. By providing an ex-
perimental system with increased biological relevance and
reducing the overall sample volumes required for experimen-
tation, microfluidic platforms have the potential to surpass a
variety of currently used screening techniques in the field of
anti-viral drug discovery [24]. Precise manipulation of test
conditions coupled with single-cell analyses also makes
microfluidic platforms unique in their ability to precisely con-
trol the microenvironment, a factor that greatly influences ex-
perimental outcomes during cell biological investigations of
drug efficacy.
Notably, two recent studies into the infectivity of murine
norovirus (MNV) have utilised droplet-based microfluidic
platforms to test the efficacy of neutralising antibodies and
investigate their impact on virus-cell interactions [25, 26]. In
comparison to current techniques used to measure viral load,
including plaque assays and quantitative polymerase chain
reaction (qPCR) analyses, microfluidic technologies signifi-
cantly reduce reaction volumes while providing an increased
amount of information, by demonstrating the heterogeneous
responses to inhibitory compounds within a cell/viral popula-
tion. By allowing parallel identification of both sensitive and
resistant viruses, these screening systems also have the poten-
tial to estimate the potential for viral resistance to novel ther-
apeutic agents prior to their clinical use.
The field of vaccine development may also benefit from
microfluidic technologies as demonstrated by a recent study
which used a droplet-based platform to perform parallel
screening and sorting of human immunodeficiency virus 1
(HIV-1) virions by epitope expression [27••]. This system es-
sentially acts as a miniaturised flow cytometer, enabling
fluorescence-based sorting of viral particles possessing anti-
genic envelope proteins. Genomic sequencing of envelope
proteins in viral populations expressing antibody-binding epi-
topes has the potential to reveal novel candidate targets for
HIV vaccines [27••].
While flow cytometric analyses of viral particles have been
previously difficult due to size restrictions, microfluidic de-
vices allow miniaturisation of this technology and its subse-
quent application to smaller viruses outside the threshold for
detection via traditional FACS methods. With the potential to
allow high-throughput epitope screening using vast libraries
of viruses, these techniques may reform the field of vaccine
development, for viruses as well as for other microorganisms.
Microfluidic Platforms for the Study of Viral Cell
Biology and Virus-Host Interactions
In recent years, several virologists and cell biologists alike
have utilised microfluidic technologies for the study of viruses
and their interactions with host cells. Moreover, it is becoming
apparent that microfluidic platforms offer unique experimen-
tal set-ups for a broad range of biological investigations,
which cannot be mimicked by widely used macroscale
techniques.
Perhaps the most widespread application of microfluidics
in virology lies in the study of viral entry processes, which can
be performed within microfluidic devices with a high degree
of precision.
Microfluidic devices have been utilised in a collection of
research studies, to investigate influenza virus fusion kinetics
[28–30, 31•]. In one such study, microfluidic flow cells con-
taining synthetic vesicles with the ability to bind viruses in the
absence of native receptors were utilised to investigate the
dependence of viral fusion on receptor binding [28]. Lipid
mixing measurements were used to record fusion events in
this system, which confirmed that receptor binding and fusion
are in fact separate dynamic processes in viral entry [28]. A
Curr Clin Micro Rpt
second investigation explored whether differential expression
of influenza virus haemagglutinin (HA)/neuraminidase (NA)
proteins in synthetic vesicular stomatitis virus (VSV) particles
could predict efficient viral fusion [30]. Researchers found
that the specific pattern of HA/NA expression in an individual
virus could reliably predict fusion kinetics in target mem-
branes. A further study examined the links between mem-
brane composition and viral fusion kinetics [31•]. This re-
search revealed that IAV fusion is significantly dependent on
membrane cholesterol content as well as sialic acid donor
availability [31•]. Since viral fusion behaviours are highly
dependent on pH level, the precise manipulation of microen-
vironmental pH in both space and time offered bymicrofluidic
devices would have been a unique advantage for each of these
studies.
These kinetic fusion studies could also be applied to drug
screening experiments, as suggested by Mashagi et al., in a
recent paper demonstrating that a droplet-based microfluidic
platform could efficiently measure IAV fusion kinetics with a
high degree of temporal resolution [29]. Droplet-based sys-
tems that provide dynamic information regarding the phase of
viral replication affected by inhibitory compounds have the
potential to provide researchers with a large amount of infor-
mation regarding the mechanisms of action of candidate anti-
viral compounds and could serve as valuable tools for HTS in
the development of anti-viral therapeutics.
Microfluidic technologies have also been applied to inves-
tigate viral replication. Several studies have used microfluidic
chips, coupled with fluorescent imaging to quantify viral rep-
lication in a variety of cell types [32, 33]. That microfluidic
techniques have proved highly compatible with live imaging
experiments further validates their usefulness for this purpose.
Microfluidics in Single-Cell Analyses
As well as population-wide information, droplet-based
microfluidic platforms can be used for single-cell analysis of
infective processes. One recent study utilised a microfluidic
chip connected to a fluorescence microscope to image polio-
virus infections in real time, in thousands of individual cells
[34]. The study revealed that microfluidic techniques could
allow efficient visualisation of thousands of individual infec-
tion events and subsequent examination of variable infection
dynamics within single cells originating from the same popu-
lation. This study also utilised their single-cell platform for
drug screening experiments, demonstrating that population-
wide effects of candidate inhibitory compounds do not accu-
rately portray the between-cell variation that exists within a
heterogeneous population of cells and viruses [34]. With the
ability to meticulously regulate cellular microenvironment
and compound application, this platform provides an efficient
technique for anti-viral drug screening in comparison to
macroscale studies, where environmental factors and drug dif-
fusion are likely to be less controlled.
In addition to acting as a stand-alone research platform for
single-cell analyses, microfluidic set-ups can also serve as
valuable tools for cell isolation, prior to detailed analyses. A
recent study utilised a droplet-based microfluidic platform
which allowed barcoding of cells based on RNA expression
and subsequent detailed analyses of cellular transcriptomics
[35••]. An array of studies have also performed proteomic and
genomic characterisation of single, virus-infected cells [36]. In
each of these studies, cell isolation was a fundamental prereq-
uisite to single-cell analysis. Microfluidics may provide an
efficient technique for sequestering single cells, prior to de-
tailed investigations of genetic and proteomic phenotypes
using a wide variety of techniques. This was demonstrated
by a recent study in which the cellular transcriptome in cells
susceptible to HIV-1 infection utilised microfluidic chips for
single-cell isolation [37].
The wide variety of cell biological processes in infection
which could be investigated usingmicrofluidic set-ups such as
those discussed above provides an insight into the enormous
potential of these techniques in virus research. Using
microfluidic chips to study infection dynamics may provide
mechanistic information regarding underlying biological pro-
cesses mediating the effects of inhibitory compounds or ma-
nipulation of host-cell factors, with a higher degree of spatial
and temporal resolution than traditional approaches. In addi-
tion, single-cell analyses are able to circumvent population
bias and provide detailed snapshots into the dynamic infection
process in unique cell and viral populations, contained within
specialised microenvironments.
The Advantages of Microfluidic Platforms
in Viral Cell Biology
While microfluidic technologies provide useful platforms for
experimentation in the field of virology, their widespread ap-
plication depends on their ability to offer significant advan-
tages over widely available and well tested techniques. The
collection of studies recently performed in the field points to
valuable uses for microfluidic platforms in particular areas of
cell biological and virological research.
While studying viral infections at a population-wide level
has provided valuable information regarding infection dynam-
ics and facilitated investigation into the effects of countless
anti-viral agents, these macroscale studies will always be as-
sociated with some degree of population bias. Overlooking
important phenotypical differences in infection dynamics
within a cell or viral population means that macroscale tech-
niques often miss unique characteristics which may convey
altered susceptibilities to infection or drug treatment. These
rare characteristics themselves have the potential to reveal
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important information regarding the mechanisms which un-
derlie host cell permissiveness to infection, viral resistance to
therapy, and viral evolution. Studying single-cell infections
using a droplet-based microfluidics system in combination
with systems biology investigations could therefore provide
a level of detail previously inaccessible to macroscale tech-
niques alone. Microfluidic platforms may also prove uniquely
advantageous for live, viral imaging experiments for inhibito-
ry compound screening. Visualising infection dynamics in
single, drug treated cells could provide a wealth of informa-
tion in HTS experiments regarding both compound efficacy
and mechanisms of action.
In contrast to macroscale techniques, microfluidic single-
cell analyses offer superior control over numerous experimen-
tal conditions. Precise concentration gradients of candidate
inhibitory compounds as well as viral particles can be created
with ease within a microfluidic chip and physical factors
which may alter infection outcome such as temperature and
pH that can also be precisely manipulated. In macroscale stud-
ies, these conditions are often difficult to regulate precisely,
and some variation in microenvironment will always exist
between individual cells within a population. The ability to
precisely control a given experimental environment is there-
fore an extremely useful and unique aspect of microfluidic-
based platforms, which in combination with macroscale stud-
ies may allow development of a more controlled and biolog-
ically relevant model system for studying infection dynamics.
Conclusions
While advancing research techniques in a wide variety of sci-
entific fields, microfluidic platforms remain an untapped re-
source in the field of virology. With the potential to improve
investigatory techniques in viral diagnostics, drug discovery,
and vaccine development, microfluidic platforms may repre-
sent a novel clinical toolset with significant impact in the field.
Viral cell biology research may also benefit significantly from
wider application of microfluidic techniques. With the ability
to provide detailed insights into the unique and dynamic inter-
actions between single cells and viruses, these platforms could
serve to enrich our understanding of the cell biology of infec-
tion. By allowing precise and highly regulated spatial and tem-
poral application of both viruses and drugs, microfluidic sys-
tems also offer more precise control and manipulation of sev-
eral key experimental parameters. The high degree of control
over cellular microenvironment offered by droplet-based
microfluidic systems may be unparalleled by macroscale in-
vestigations. Since viral infection is a complex and highly dy-
namic process, significantly affected by the physical and chem-
ical environment, studies into infection biology should ideally
take place within a stable and controlled experimental com-
partment, such as that provided by a microfluidics system.
For these reasons, microfluidic platforms provide novel tools
for studies in infection biology, with unique capabilities.
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